(Reuters) – Bausch Health Companies Inc said on Thursday that it is suspending its plans for the initial public offering of its unit Solta Medical, citing challenging market conditions.
Bausch said it will revisit alternative paths for the medical aesthetics company in future.
In August, Bausch announced plans to pursue an IPO of Solta in a bid to shed non-core assets and cut down debt.
(Reporting by Leroy Leo in Bengaluru; Editing by Maju Samuel)
